InvestorsHub Logo
Followers 32
Posts 1169
Boards Moderated 0
Alias Born 12/12/2005

Re: None

Tuesday, 07/17/2012 11:35:50 PM

Tuesday, July 17, 2012 11:35:50 PM

Post# of 346071

Second line non-small cell lung cancer represents a large market with over 135,000 drug-treatable patients annually in the U.S., Europe and Japan. Currently, over $1 billion annually is spent treating these patients...


I was looking at these figures and pluging in a cost of $40,000.00 per patient for bavi equates to potential sales of $5.4 billion.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News